Endometriosis Trial, Recruiting NCT07232485 Sponsor: University of Edinburgh Condition: Endometriosis
Back to Endometriosis

Endometriosis Trial, Recruiting

NCT07232485
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

For people with a diagnosis of endometriosis:

  • Women and people assigned female at birth who have not yet reached menopause
  • Aged 18 years or older
  • Have been diagnosed with endometriosis through surgery or medical imaging within the last 5 years
  • Able to understand and willing to sign a consent form

For healthy volunteers (no endometriosis):

  • Women and people assigned female at birth
  • Aged 18 years or older
  • No history of endometriosis or ongoing pelvic pain
  • Able to understand and willing to sign a consent form

Who may not be able to join:

For both groups:

  • Those who have donated blood (450 ml) in the last 4 weeks
  • Those with a known cancer of the reproductive tract
  • Those with diagnosed eye conditions such as glaucoma, optic nerve disease, cataracts, macular degeneration, or retinal disorders
  • Those with a very strong glasses or contact lens prescription (high short-sightedness, long-sightedness, or significant astigmatism — confirm exact thresholds with trial site)
  • Those who have had eye surgery, such as laser vision correction or retinal surgery
  • Those with significant eye injury, corneal problems, or an active eye infection
  • Those with diabetes

Additionally, for healthy volunteers only:

  • Those who have experienced symptoms that may suggest endometriosis or long-term pelvic pain

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Andrew Horne, University of Edinburgh

Phone: +447301394870

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University of Edinburgh
Registry
ClinicalTrials.gov
Start date
3 September 2025
Est. completion
1 August 2029

Where this trial is recruiting

🇬🇧 United Kingdom

Primary endpoints

Choroidal Thickness (Optical Coherence Tomography, Heidelberg SPECTRALIS); Retinal Thickness (Optical Coherence Tomography, Heidelberg SPECTRALIS); Retinal Nerve Fiber Layer (RNFL) Thickness (Optical Coherence Tomography, Heidelberg SPECTRALIS); Macular Volume (Optical Coherence Tomography, Heidelberg SPECTRALIS); Retinal Vessel Density (Optical Coherence Tomography Angiography, Heidelberg SPECTRALIS)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov